Copart stock downgraded by HSBC on weak insurance volumes

HSBC, a prominent investment firm, has downgraded Copart's stock to 'Hold' from 'Buy' due to challenges faced in the company's insurance business and slowing growth. The downgrade comes with a price target of $36.00, which is lower than the current trading price of $30.82. HSBC's assessment highlights a 7.5% decline in U.S. insurance volumes for Copart during the fourth quarter of fiscal 2026, while rival RB Global reported an 11% increase in auto volumes during the same period.

The stock has faced a 34% decline over the past year, adding to the investor concerns. HSBC's analysts have noticed that several key costs for Copart, such as facilities and general and administrative expenses, have grown faster than the company's revenue. Furthermore, HSBC points out that the average selling price growth, which once supported revenue growth, is now experiencing a decline.

While HSBC expects a difficult 2027, the firm believes the weakness in Copart's performance might be a temporary adjustment process, with volumes shifting from insurers to RB Global. However, this process could take longer than anticipated, potentially leading to further declines. Despite these challenges, HSBC believes Copart's proposed acquisition of ACV Auctions may not be substantial enough to offset the current weakness in the insurance business.

The acquisition, however, could bring dilutive effects on earnings per share in the short term, but accretive benefits in the long run. Investors can refer to HSBC's Pro Research Report for a more in-depth analysis of Copart's prospects.